Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 3Recruiting 2Not yet recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Warts 2Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × 2-Propanol × Clear all
NCT05441514 2026-05-05

Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed
502 enrolled 22 charts

Warts

NCT03687372 2020-10-05

Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed
503 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡